Joint Venture to Open Biosimilar Lab in Brazil
(World News Brazil)

PlantForm Corporation, a Canadian biotech firm, has announced that it will begin construction this summer on a new biopharmaceutical lab in Rio de Janeiro with its partner, Brazil-based Axis Biotec Brasil. According to PlantForm`s press release, the joint venture, known as PlantPraxis, `will first develop a biosimilar version of adalimumab for rheumatoid arthritis and other inflammatory disorders.` ......